{"nct_id":"NCT04616326","title":"A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine","status":"RECRUITING","status_verified_date":"2025-07","start_date":"2020-11-25","start_date_type":"ACTUAL","primary_completion_date":"2025-07","primary_completion_date_type":"ESTIMATED","completion_date":"2026-03","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["LLY"]}